InvestorQ : Why has Reddy Labs been outperforming in the markets of late?
Deepa Salunkhe made post

Why has Reddy Labs been outperforming in the markets of late?

Answer
image
Arya Nanda answered.
1 month ago
Follow

Dr. Reddy’s Laboratories surged 3.4% to Rs4,554 post launch of its generic version of fesoterodine fumarate to treat overactive bladder in the US markets. This is already approved by USFDA in 4 mg and 8 mg tablets. Its annual US market is estimated at $211 million. Its next big focus area for the Indian market is going to be Nutraceuticals and OTC segments where its presence is currently quite small.

5 Views